ALEXANDER J DENNER
CIK 1361754 · last filed 2026-06-17
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$170.86M
Companies
9
Total Filings
102
Lifetime Open-Market Net
$292.27M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| IRWD | Director | 9,518,290 | $3.65 | $34.79M | -$3.12M | 23 | 2026-06-17 |
| BIIB | Director | 658,099 | $206.77 | $136.08M | $165.91M | 24 | 2022-06-17 |
| MEDICINES CO /DE (MDCO) Delisted | Director | 0 | — | — | $63.34M | 16 | 2020-01-06 |
| Bioverativ Inc. (BIVV) Delisted | Director | 0 | — | — | $56.34M | 8 | 2018-03-08 |
| ARIAD PHARMACEUTICALS INC (ARIA) Delisted | Director | 0 | — | — | $4.96M | 6 | 2017-02-16 |
| VIVUS INC (VVUS) Delisted | Director | 242,417 | — | — | $4.87M | 4 | 2015-11-03 |
| Viskase Holdings, Inc. (ENZN) Delisted | Director | 606 | — | — | $0 | 8 | 2013-01-04 |
| AMYLIN PHARMACEUTICALS INC (AMLN) Delisted | Director | 10,161 | — | — | -$21.2K | 9 | 2012-05-17 |
| Savara Inc (ANX) Delisted | Director | — | — | — | $0 | 3 | 2008-07-08 |
Recent Filings · Page 3 of 11
102 filingsInsider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2021-07-02 | BIIB | Grant (A) | +775 | $0 | EDGAR |
| 2021-03-10 | IRWD | Buy (P) | +450,000 | $4.67M | EDGAR |
| 2021-03-02 | IRWD | Buy (P) | +1,350,000 | $12.74M | EDGAR |
| 2020-12-17 | IRWD | Grant (A) | +661 | $0 | EDGAR |
| 2020-11-09 | IRWD | Grant (A) | +37,183 | $0 | EDGAR |
| 2020-06-05 | BIIB | Grant (A) | +890 | $0 | EDGAR |
| 2020-01-06 | MEDICINES CO /DE (MDCO) Delisted | Disp (D) | −4,287,813 | $0 | EDGAR |
| 2019-06-28 | MEDICINES CO /DE (MDCO) Delisted | Buy (P) | +50,000 | $1.65M | EDGAR |
| 2019-06-20 | BIIB | Grant (A) | +1,155 | $0 | EDGAR |
| 2019-06-03 | MEDICINES CO /DE (MDCO) Delisted | Grant (A) | +3,663 | $0 | EDGAR |
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.